Stay updated on Deflazacort vs Prednisolone in ABPA Clinical Trial
Sign up to get notified when there's something new on the Deflazacort vs Prednisolone in ABPA Clinical Trial page.

Latest updates to the Deflazacort vs Prednisolone in ABPA Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal regarding the treatment and understanding of Allergic Bronchopulmonary Aspergillosis (ABPA), including detailed information about glucocorticoids and the introduction of deflazacort as a treatment option. Additionally, a new version number for the document has been added.SummaryDifference39%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 28, 2025.SummaryDifference0.4%
- Check37 days agoChange DetectedDifference0.5%
- Check44 days agoChange DetectedDifference0.5%
- Check66 days agoChange DetectedThe page has been updated to reflect a new randomized controlled trial comparing Deflazacort and Prednisolone in the treatment of acute-stage allergic bronchopulmonary aspergillosis, with new dates for the trial and last update.SummaryDifference3%
Stay in the know with updates to Deflazacort vs Prednisolone in ABPA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deflazacort vs Prednisolone in ABPA Clinical Trial page.